In neuroinflammatory diseases such as multiple sclerosis (MS), CD146 is upregulated on blood-brain barrier endothelial cells (BBB-ECs) and promotes the transmigration of inflammatory cells into the CNS 16, 17. Here, MCAM is linked to myeloid sarcoma.